A further discussion on the clinical application of TACE and HAIC for hepatocellular carcinoma
10.3969/j.issn.1008-794X.2025.02.002
- VernacularTitle:再论肝癌TACE与HAIC的联合临床应用
- Author:
Naijian GE
1
;
Yefa YANG
Author Information
1. 200438 上海 海军军医大学第三附属医院(上海东方肝胆外科医院)放射介入科
- Keywords:
hepatic arterial infusion chemotherapy;
transarterial chemoembolization;
hepatocellular carcinoma;
combination use of hepatic arterial infusion chemotherapy and transarterial chemoembolization
- From:
Journal of Interventional Radiology
2025;34(2):129-133
- CountryChina
- Language:Chinese
-
Abstract:
Transarterial chemoembolization(TACE)has been well recognized as the preferred treatment for non-surgical resection of hepatocellular carcinoma(HCC),while hepatic arterial infusion chemotherapy(HAIC)is another effective interventional method.Many studies on TACE and HAIC treatment for HCC have been reported,which has aroused widespread debate in the medical field.Reasonable combination use of HAIC and TACE is defined as infusion transarterial chemoembolization(iTACE).This paper aims to make a comprehensive introduction about iTACE,focusing on its concept,applied method,indications and contraindications,efficacy and adverse reactions,combination with targeted immunotherapy,etc.It is expected that this paper will provide useful reference for the promotion and application of iTACE in clinical practice.
